ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.37
0.46%
US Tech 100
20,656.40
0.16%
S&P 500
5,917.64
0.18%
US Dollar vs CAD
1.43806
0.21%
Bitcoin
95,331.28
2.88%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT

  6. Amgen Inc (AMGN) Share Price

Amgen Inc

Amgen Inc (AMGN)

Amgen Inc
Amgen Inc
0.00
0.00
(0.00%)
Closed December 31 10:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

AMGN Latest News

More News

Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Me

Denosumab Trial Met Primary and All Secondary Endpoints by Significantly Delaying Time to First Skeletal Related Event and Significantly Reducing First-and-Subsequent Skeletal Related Events...

February 08 2010
PR Newswire (US)

Amgen's Fourth Quarter 2009 Adjusted Earnings Per Share Decreased 1 Percent to $1.05; Full Year 2009 Adjusted Earnings Per Share

Fourth Quarter 2009 Revenue Increased 2 Percent to $3.8 Billion; Full Year 2009 Revenue Decreased 2 Percent to $14.6 Billion Fourth Quarter 2009 GAAP Earnings Per Share Increased 6 Percent to...

January 25 2010
PR Newswire (US)

Amgen Presents Complete Results From Two Pivotal Phase 3 Studies of Vectibix(R) at Gastrointestinal Cancers Symposium

THOUSAND OAKS, Calif., Jan. 21 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) today announced that detailed results from two pivotal Phase 3 studies evaluating Vectibix® (panitumumab) in...

January 21 2010
PR Newswire (US)

Amgen Announces Webcast of 2009 Fourth Quarter and Full Year Financial Results

THOUSAND OAKS, Calif., Jan. 20 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) today announced that it plans to report its fourth quarter and full year financial results on Monday, Jan. 25, 2010...

January 20 2010
PR Newswire (US)

Amgen Donates $2 Million, Establishes Earthquake Relief Program

Company, Staff Contributions To Help Haitian Victims THOUSAND OAKS, Calif., Jan. 14 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) today announced that the company will donate $2 million to Haiti...

January 14 2010
PR Newswire (US)

Amgen to Present at the 28th Annual JP Morgan Healthcare Conference

THOUSAND OAKS, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) will present at the 28th Annual JP Morgan Global Healthcare Conference at 8:00 a.m. Pacific Time on Tuesday, Jan. 12...

January 07 2010
PR Newswire (US)

Amgen Resolves EPO Patent Dispute With Roche

Roche Admits Infringement And Validity Of Amgen's EPO Patents; Court Enters Permanent Injunction; Amgen Allows Roche's MIRCERA Onto U.S. Market In Mid-2014 THOUSAND OAKS, Calif., Dec. 22...

December 22 2009
PR Newswire (US)

Amgen's Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines

THOUSAND OAKS, Calif., Dec. 18 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) announced today that Roger M. Perlmutter, M.D., Ph. D., Amgen's executive vice president of Research & Development...

December 18 2009
PR Newswire (US)

Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program

THOUSAND OAKS, Calif., Dec. 7 /PRNewswire-FirstCall/ -- Amgen (NASDAQ: AMGN) today announced that its board of directors has authorized repurchases of up to an additional $5 billion in Amgen...

December 07 2009
PR Newswire (US)

New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists

Applications for 2010 Amgen Scholars U.S. and Europe Programs Now Available THOUSAND OAKS, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Each year, hundreds of undergraduate students from across the...

December 03 2009
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

AMGN - Frequently Asked Questions (FAQ)

What is the current Amgen share price?
The current share price of Amgen is 0.00 €
What is the 1 year trading range for Amgen share price?
Amgen has traded in the range of 0.00 € to 0.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BIROEstrima Spa
0.428 €
(49.65%)
202.4k
EPHEPH SpA
0.135 €
(31.07%)
16.98k
WPAL26Palingeo SpA
0.2575 €
(28.75%)
6k
MNLMonnalisa SPA
1.89 €
(28.57%)
197.24k
WSGC28SG Company SpA
0.0287 €
(19.58%)
5.5k
WBELLBellini Nauttica Spa
0.0801 €
(-35.51%)
301
NSPNeosperience Spa
0.482 €
(-34.15%)
68k
WFAE25Fae Technology
0.4013 €
(-19.74%)
1.4k
1SRTSartorius AG
183.80 €
(-12.89%)
6
1PLDPrologis Inc
101.54 €
(-10.82%)
175
TITTelecom Italia SpA
0.2463 €
(0.16%)
117.99M
ISPIntesa Sanpaolo Spa
3.8585 €
(-0.17%)
34.46M
TITRTelecom Italia
0.2891 €
(-0.07%)
20.78M
ENELEnel Spa
6.889 €
(0.61%)
14.11M
FDAFidia
0.0478 €
(6.22%)
8.44M

Discussion

View Full Feed
02opida 02opida 50 seconds ago
GEMZ > ELEV > GMZP
GMZP
DiscoverGold DiscoverGold 1 minute ago
Cocoa nearly tripled in 2024, making it the hottest commodity of the year
By: Markets & Mayhem | December 31, 2024

• Cocoa nearly tripled in 2024, making it the hottest commodity of the year.

pbs.twimg.com/media/GgIPVU5WUAAbs2L?format=png&name=large
RIGATONI RIGATONI 1 minute ago
~ZEOX $4.73 high with a very nice buy opp on this year end pull back. News highs coming and an uplist to the big boards. Search the board, numerous drugs in the pipeline and a tiny floater
ZEOX
Konaploinks Konaploinks 1 minute ago
Nothing but fantastic news and there’s a concerted effort to crash the price. Somebody is scared. I wonder who it is?
IONQ
02opida 02opida 1 minute ago
ROKU > PHUN > PSYC
PHUN PSYC ROKU
tw0122 tw0122 1 minute ago
.... style="caret-color: rgb(0, 0, 0); color: rgba(0, 0, 0, 1); font-family: -apple-system; font-size: 15px" 10:49 AM EST, 12/11/2024 (MT Newswires) -- New Era Helium (NEHC) said Wednesday it signed a binding letter of intent with Sharon AI to develop and operate a 250-megawatt, net-zero energy data
NEHC
SC8 SC8 1 minute ago
Point is many here wrongly blame FDA for MK's incompetence to even ask FDA for human trial authorization. There's nothing for FDA to consider until MK bothers to submit an IDE application. To date he hasn't. How is MK's incompetence FDA's fault?
RDGL
02opida 02opida 2 minutes ago
INDD > INAB > PLUG
INAB
02opida 02opida 2 minutes ago
RONN > RWGI > TPTW
RWGI TPTW
dirkv dirkv 2 minutes ago
HIGH RISK!!!
Matinas BioPharma Holdings, Inc. (MTNB) : 0.53
52w: 0.48 - 21.5
I think a end value of 2.5 – 3 is possible If they find a buyer for MAT2203, without a buyer 1 - 1.5

Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations und
MTNB
trader59 trader59 2 minutes ago
Computer generated wash trading, brazen illegal manipulation of the stock price. The O/S here is 3.8M, already traded 15 times over at 10:15. Don't get trapped with grossly overpriced stock when they turn the computers off.
APM
dirkv dirkv 2 minutes ago
HIGH RISK!!!
Matinas BioPharma Holdings, Inc. (MTNB) : 0.53
52w: 0.48 - 21.5
I think a end value of 2.5 – 3 is possible If they find a buyer for MAT2203, without a buyer 1 - 1.5

Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations und
MTNB
02opida 02opida 2 minutes ago
KGKG > GXXM > GTCH
GTCH GXXM KGKG
Debunkinator Debunkinator 2 minutes ago
Link, looks like you better start Island hunting. 😉 🚀💰️
ASII
mr34 mr34 3 minutes ago
“Tax loss selling” is the latest excuse
SDRC
02opida 02opida 3 minutes ago
TOI > NEXI > NKLA
NEXI NKLA TOI
NEnorth NEnorth 3 minutes ago
what will things look like in a week??
CBRF
Ms Labonte Ms Labonte 3 minutes ago
Shortie$$running out of ammo$$$
RUNNING
Catpole Catpole 3 minutes ago
If I am not mistaken any selling today will not count as a tax loss. That ended yesterday.
APRU
02opida 02opida 3 minutes ago
BNET > BINP > BLEG
BLEG
RIGATONI RIGATONI 3 minutes ago
$1.50 New high ~Rig
pos_stock_hoarder pos_stock_hoarder 3 minutes ago
Perfect summation of their ilk.
Ms Labonte Ms Labonte 3 minutes ago
Drop your pant$$ short junkie$$$
RNAZ
02opida 02opida 3 minutes ago
TOBP

Your Recent History

BIT
AMGN
Amgen
USOTC
NTRR
Neutra (PK)
NASDAQ
APP
Applovin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads